Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy

Pancreatic ductal adenocarcinoma (PDAC) remains an extremely aggressive disease characterized by rapidly acquired multi-drug resistance, including to first-line chemotherapeutic agent gemcitabine. Autophagy is a process that is often exploited by cancer and is one of several intrinsic factors associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin-Muller, Christian, Li, Dali, Lü, Jian-Ming, Liang, Zhengdong, Vega-Martínez, Osvaldo, Crawford, Sue E., Estes, Mary K., Fisher, William E., Chen, Changyi, Yao, Qizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457905/
https://www.ncbi.nlm.nih.gov/pubmed/37631252
http://dx.doi.org/10.3390/pharmaceutics15082038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457905/
https://www.ncbi.nlm.nih.gov/pubmed/37631252
http://dx.doi.org/10.3390/pharmaceutics15082038

Ejemplares similares